Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0097 | 1 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |